HomeCompareDITEX vs JNJ

DITEX vs JNJ: Dividend Comparison 2026

DITEX yields 2.66% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DITEX wins by $232.39M in total portfolio value
10 years
DITEX
DITEX
● Live price
2.66%
Share price
$12.71
Annual div
$0.34
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$232.41M
Annual income
$216,756,030.77
Full DITEX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DITEX vs JNJ

📍 DITEX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDITEXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DITEX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DITEX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DITEX
Annual income on $10K today (after 15% tax)
$226.05/yr
After 10yr DRIP, annual income (after tax)
$184,242,626.15/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DITEX beats the other by $184,241,922.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DITEX + JNJ for your $10,000?

DITEX: 50%JNJ: 50%
100% JNJ50/50100% DITEX
Portfolio after 10yr
$116.22M
Annual income
$108,378,429.27/yr
Blended yield
93.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DITEX
No analyst data
Altman Z
1.9
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DITEX buys
0
JNJ buys
0
No recent congressional trades found for DITEX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDITEXJNJ
Forward yield2.66%3.36%
Annual dividend / share$0.34$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR100%5.8%
Portfolio after 10y$232.41M$20.0K
Annual income after 10y$216,756,030.77$827.78
Total dividends collected$231.23M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DITEX vs JNJ ($10,000, DRIP)

YearDITEX PortfolioDITEX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,232$531.88$10,676$355.77+$556.00DITEX
2$13,135$1,116.64$11,407$389.39+$1.7KDITEX
3$16,495$2,440.78$12,198$426.53+$4.3KDITEX
4$23,379$5,729.33$13,056$467.62+$10.3KDITEX
5$40,194$15,178.32$13,987$513.12+$26.2KDITEX
6$91,783$48,775.75$14,998$563.56+$76.8KDITEX
7$306,395$208,187.21$16,098$619.52+$290.3KDITEX
8$1,626,873$1,299,030.59$17,295$681.69+$1.61MDITEX
9$14,633,265$12,892,510.36$18,599$750.82+$14.61MDITEX
10$232,413,624$216,756,030.77$20,022$827.78+$232.39MDITEX

DITEX vs JNJ: Complete Analysis 2026

DITEXStock

The investment seeks the maximum amount of current income exempt from federal income tax as is consistent with the preservation of capital. The fund invests at least 80% of its assets in municipal bonds rated, at the time of purchase, A or higher or the unrated equivalent as determined by the adviser. The fund may invest up to 20% of its assets in municipal bonds rated below A, including bonds rated below investment grade ("high yield" or "junk" bonds) or the unrated equivalent as determined by the adviser. The dollar-weighted average maturity of the fund&#39;s portfolio generally is between three and ten years.

Full DITEX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DITEX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DITEX vs SCHDDITEX vs JEPIDITEX vs ODITEX vs KODITEX vs MAINDITEX vs ABBVDITEX vs MRKDITEX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.